Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected
As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
Visby Medical to Exhibit at Emergency Nursing 2022
Visby will be exhibiting at Emergency Nursing 2022 (ENA), a premier professional nursing conference dedicated to defining the future of emergency nursing through advocacy, education, research, innovation, leadership, and more.
Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby
Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.
Visby Medical to Exhibit at ACEP 2022 Scientific Assembly
Join Visby Medical at ACEP 2022, an educational and networking conference hosted by the American College of Emergency Physicians.
Visby to Exhibit at the 28th AACC International CPOCT Symposium
Come see Visby Medical at the 28th AACC International CPOCT Symposium, a gathering designed to meet the needs of laboratory professionals.
Visby Collaborates with Urgent Care Leaders in Scottsdale, AZ
Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.
Why Should We Test for Trichomonas?
Trichomoniasis, commonly known as “trich,” is one of the most common sexually transmitted infections (STIs). It is caused by a one-celled parasite, Trichomonas vaginalis. Men and women are affected by this infection, but it occurs more often in women.
Video Highlights from Visby Medical’s Breakfast Panel at 2022 IDSOG Annual Meeting
Watch video highlights from “The Neglected Epidemic: A Panel Discussion about the Value Rapid POC PCR brings to Reproductive Health” panel discussion at the 2022 IDSOG Annual Meeting.
